Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1993 Jun;67(6):1437–1439. doi: 10.1038/bjc.1993.266

Amino acid infusion blocks renal tubular uptake of an indium-labelled somatostatin analogue.

P J Hammond 1, A F Wade 1, M E Gwilliam 1, A M Peters 1, M J Myers 1, S G Gilbey 1, S R Bloom 1, J Calam 1
PMCID: PMC1968533  PMID: 8099808

Abstract

The Indium-labelled somatostatin analogue pentetreotide has been successfully developed for imaging of somatostatin receptor positive tumours. However there is significant renal tubular uptake of the radiolabelled peptide, which can obscure upper abdominal tumours and would preclude its use for targeted radiotherapy. The aim of this study was to determine whether amino acid infusion, which has been shown to block renal tubular peptide reabsorption, diminishes renal parenchymal uptake of this radiolabelled analogue. Eight patients being scanned with the 111In-labelled somatostatin analogue, pentetreotide, for localisation of gastroenteropancreatic tumours received an infusion of synthetic amino acids. The ratio of isotope uptake in kidney to that in spleen was assessed, and compared to the ratio for matched control patients, to determine if amino acid infusion reduced renal parenchymal uptake of the radiopharmaceutical. The amount of isotope in the urine was determined to ensure that any effect of the amino acid infusion was unrelated to changes in clearance. Infusion of amino acids significantly reduced renal parenchymal uptake of isotope at 4 h. There was a non-significant increase in urinary clearance of isotope over the 4 h, consistent with reduced reuptake and a lack of effect on glomerular filtration rate. This technique, by preventing renal damage, may allow the use of this somatostatin analogue for local radiotherapy, and could be of wider value in blocking tubular re-uptake of potentially nephrotoxic agents, such as radiolabelled Fab fragments.

Full text

PDF
1437

Images in this article

1438Figure 1
on p.1438

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abel R. M., Beck C. H., Jr, Abbott W. M., Ryan J. A., Jr, Barnett G. O., Fischer J. E. Improved survival from acute renal failure after treatment with intravenous essential L-amino acids and glucose. Results of a prospective, double-blind study. N Engl J Med. 1973 Apr 5;288(14):695–699. doi: 10.1056/NEJM197304052881401. [DOI] [PubMed] [Google Scholar]
  2. Buijs W. C., Massuger L. F., Claessens R. A., Kenemans P., Corstens F. H. Dosimetric evaluation of immunoscintigraphy using indium-111-labeled monoclonal antibody fragments in patients with ovarian cancer. J Nucl Med. 1992 Jun;33(6):1113–1120. [PubMed] [Google Scholar]
  3. Castellino P., Hunt W., DeFronzo R. A. Regulation of renal hemodynamics by plasma amino acid and hormone concentrations. Kidney Int Suppl. 1987 Oct;22:S15–S20. [PubMed] [Google Scholar]
  4. Dorr R. T. Chemoprotectants for cancer chemotherapy. Semin Oncol. 1991 Feb;18(1 Suppl 2):48–58. [PubMed] [Google Scholar]
  5. Krenning E. P., Bakker W. H., Kooij P. P., Breeman W. A., Oei H. Y., de Jong M., Reubi J. C., Visser T. J., Bruns C., Kwekkeboom D. J. Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide. J Nucl Med. 1992 May;33(5):652–658. [PubMed] [Google Scholar]
  6. Lamberts S. W., Krenning E. P., Reubi J. C. The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr Rev. 1991 Nov;12(4):450–482. doi: 10.1210/edrv-12-4-450. [DOI] [PubMed] [Google Scholar]
  7. Larson S. M. Clinical radioimmunodetection, 1978-1988: overview and suggestions for standardization of clinical trials. Cancer Res. 1990 Feb 1;50(3 Suppl):892s–898s. [PubMed] [Google Scholar]
  8. Mogensen C. E., Sølling Studies on renal tubular protein reabsorption: partial and near complete inhibition by certain amino acids. Scand J Clin Lab Invest. 1977 Oct;37(6):477–486. doi: 10.3109/00365517709101835. [DOI] [PubMed] [Google Scholar]
  9. Wong N. L., Magil A. B., Dirks J. H. Effect of magnesium diet in gentamicin-induced acute renal failure in rats. Nephron. 1989;51(1):84–88. doi: 10.1159/000185248. [DOI] [PubMed] [Google Scholar]
  10. Zager R. A. Amino acid hyperalimentation in acute renal failure: a potential therapeutic paradox. Kidney Int Suppl. 1987 Oct;22:S72–S75. [PubMed] [Google Scholar]
  11. Zager R. A., Johannes G., Tuttle S. E., Sharma H. M. Acute amino acid nephrotoxicity. J Lab Clin Med. 1983 Jan;101(1):130–140. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES